نتایج جستجو برای: mdk

تعداد نتایج: 338  

2015
Jingyan Luo Xiaoxiao Wang Zhibo Xia Lixuan Yang Zhiming Ding Shiyuan Chen Bingquan Lai Nu Zhang

Midkine (MDK) expression is associated with the proliferation of many cancers, including glioma. However, the upstream signaling that leads to MDK accumulation remains elusive. This study investigates the molecular mechanism that induces MDK overexpression in human glioma. The Repository for Molecular Brain Neoplasia Data was analyzed to identify potential MDK regulators. Expression of MDK and ...

2015
Karim Y. A. Shaheen Abeer I. Abdel-Mageed Eslam Safwat Ashraf M. AlBreedy

Background and Aim. Identification of sensitive biomarkers to improve early diagnosis of HCC is needed. We aimed to evaluate serum midkine (MDK) as a biomarker for HCC diagnosis. Patients and Methods. 40 HCCs, 30 liver cirrhosis patients, and 30 healthy subjects were enrolled. Serum MDK using ELISA was measured in all included subjects. Results. Serum MDK was significantly elevated in HCC group...

2016
Melanie Haffner-Luntzer Julia Kemmler Verena Heidler Katja Prystaz Thorsten Schinke Michael Amling Anna Kovtun Anna E. Rapp Anita Ignatius Astrid Liedert

The heparin-binding growth and differentiation factor midkine (Mdk) is proposed to negatively regulate osteoblast activity and bone formation in the adult skeleton. As Mdk-deficient mice were protected from ovariectomy (OVX)-induced bone loss, this factor may also play a role in the pathogenesis of postmenopausal osteoporosis. We have previously demonstrated that Mdk negatively influences bone ...

2016
Melanie Haffner-Luntzer Aline Heilmann Anna Elise Rapp Robin Roessler Thorsten Schinke Michael Amling Anita Ignatius Astrid Liedert

BACKGROUND AND PURPOSE Previous findings suggest that the growth and differentiation factor midkine (Mdk) is a negative regulator of osteoblast activity and bone formation, thereby raising the possibility that a specific Mdk antagonist might improve bone formation during fracture healing. EXPERIMENTAL APPROACH In the present study, we investigated the effects of a monoclonal anti-Mdk antibody...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Wen-Wei Zhu Jia-Jian Guo Lei Guo Hu-Liang Jia Ming Zhu Ju-Bo Zhang Christopher A Loffredo Marshonna Forgues Hua Huang Xu-Jian Xing Ning Ren Qiong-Zhu Dong Hai-Jun Zhou Zheng-Gang Ren Nai-Qing Zhao Xin Wei Wang Zhao-You Tang Lun-Xiu Qin Qing-Hai Ye

PURPOSE To evaluate the value of serum midkine (MDK) as a diagnostic biomarker in hepatocellular carcinoma, particularly for those with negative alpha-fetoprotein (AFP) and at an early stage. EXPERIMENTAL DESIGN MDK expression in tumors was assessed by immunohistochemistry from 105 patients with hepatocellular carcinomas or liver cirrhosis. Serum MDK levels were detected by ELISA in 933 parti...

2017
Kathleen C. Woulfe Carmen C. Sucharov

Midkine (MDK) is a heparin-binding growth factor that is normally expressed in mid-gestational development mediating mesenchymal and epithelial interactions. As organisms age, expression of MDK diminishes; however, in adults, MDK expression is associated with acute and chronic pathologic conditions such as myocardial infarction and heart failure (HF). The role of MDK is not clear in cardiovascu...

2016
Roslyn Vongsuvanh David van der Poorten Tristan Iseli Simone I. Strasser Geoffrey W. McCaughan Jacob George

UNLABELLED Robust biomarkers for population-level hepatocellular carcinoma (HCC) surveillance are lacking. We compared serum midkine (MDK), dickkopf-1 (DKK1), osteopontin (OPN) and AFP for HCC diagnosis in 86 HCC patients matched to 86 cirrhotics, 86 with chronic liver disease (CLD) and 86 healthy controls (HC). Based on the performance of each biomarker, we assessed a separate longitudinal coh...

2014
Melanie Haffner-Luntzer Aline Heilmann Anna Elise Rapp Simon Beie Thorsten Schinke Michael Amling Anita Ignatius Astrid Liedert

The growth and differentiation factor midkine (Mdk) plays an important role in bone development and remodeling. Mdk-deficient mice display a high bone mass phenotype when aged 12 and 18 months. Furthermore, Mdk has been identified as a negative regulator of mechanically induced bone formation and it induces pro-chondrogenic, pro-angiogenic and pro-inflammatory effects. Together with the finding...

2013
Huifang Hao Yutaka Maeda Takuya Fukazawa Tomoki Yamatsuji Munenori Takaoka Xiao-Hong Bao Junji Matsuoka Tatsuo Okui Tsuyoshi Shimo Nagio Takigawa Yasuko Tomono Motowo Nakajima Iris M. Fink-Baldauf Sandra Nelson William Seibel Ruben Papoian Jeffrey A. Whitsett Yoshio Naomoto

Midkine (MDK) is a heparin-binding growth factor that is highly expressed in many malignant tumors, including lung cancers. MDK activates the PI3K pathway and induces anti-apoptotic activity, in turn enhancing the survival of tumors. Therefore, the inhibition of MDK is considered a potential strategy for cancer therapy. In the present study, we demonstrate a novel small molecule compound (iMDK)...

2010
Gregory E Rice Tracey A Edgell Dominic J Autelitano

The aims of this study were: to characterise and compare plasma concentrations of midkine (MDK) in normal healthy women with concentrations observed in women with ovarian cancer; and to establish and compare the performance of MDK with that of anterior gradient 2 protein (AGR2) and CA125 in the development of multi-analyte classification algorithms for ovarian cancer. Median plasma concentratio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید